| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |